ACETAZOLAMIDE ( DrugBank: Acetazolamide )


6 diseases
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica1
90Retinitis pigmentosa1
115Hereditary periodic paralysis1
155Acquired aphasia with convulsive disorder1
225Congenital nephrogenic diabetes insipidus1
230Alveolar hypoventilation syndrome1

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,340Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

90. Retinitis pigmentosa


Clinical trials : 147Drugs : 176 - (DrugBank : 43) / Drug target genes : 49 - Drug target pathways : 110 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

115. Hereditary periodic paralysis


Clinical trial : 1Drugs : 2 - (DrugBank : 2) / Drug target genes : 13 - Drug target pathways : 7 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

155. Acquired aphasia with convulsive disorder


Clinical trial : 1Drugs : 2 - (DrugBank : 2) / Drug target genes : 29 - Drug target pathways : 14 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

225. Congenital nephrogenic diabetes insipidus


Clinical trials : 15Drugs : 48 - (DrugBank : 18) / Drug target genes : 31 - Drug target pathways : 65 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

230. Alveolar hypoventilation syndrome


Clinical trials : 6Drugs : 7 - (DrugBank : 4) / Drug target genes : 16 - Drug target pathways : 26 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries